Sozinibercept - CAS 2568358-31-4

Sozinibercept (OPT 302; VGX-300) is a soluble form of Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) that potently inhibits the activity of Vascular Endothelial Growth Factor-C and -D (VEGF-C/D), key proangiogenic factors involved in promoting angiogenesis and vascular leakage. Additionally, Sozinibercept has been shown to inhibit diabetic retinal edema in rats [1] [2] [3].

VEGFR

Tyrosine Kinase/Adaptors, Angiogenesis

2568323

-20°C

Ice Packs

Inhibitory Antibodies